Nicholas Swenson - Pro Dex Independent Chairman of the Board

PDEX Stock  USD 17.41  0.19  1.10%   

Chairman

Mr. Nicholas John Swenson is Independent Chairman of the Board of the Company. He has served as the managing partner of AO Partners, LLC since January 2012. He has also served as President and Chief Executive Officer of Air T, Inc., a Nasdaq listed company, since October 2013, as Chairman of the Board since August 2013 and as a member of the Board of Directors since August 2012. Mr. Swenson serves as a director of several private companies as well. Also, since March 2009, Mr. Swenson was the Portfolio Manager of Groveland Capital, LLC. Prior to forming Groveland Capital, Mr. Swenson was a Portfolio Manager and Partner at Whitebox Advisors, LLC, a multistrategy hedge fund, from 2001 to 2009. From 1999 to 2001 he was a research analyst at Varde Partners, LLC, a partnership that specializes in distressed debt investing. He was an Associate in Corporationrationrate Finance at Piper Jaffray, Inc. from 1996 to 1999 since 2013.
Age 49
Tenure 11 years
Professional MarksMBA
Address 2361 McGaw Avenue, Irvine, CA, United States, 92614
Phone949 769 3200
Webhttps://www.pro-dex.com
Swenson has a B.A. degree in History from Middlebury College and an M.B.A. from the University of Chicago .

Nicholas Swenson Latest Insider Activity

Tracking and analyzing the buying and selling activities of Nicholas Swenson against Pro Dex stock is an integral part of due diligence when investing in Pro Dex. Nicholas Swenson insider activity provides valuable insight into whether Pro Dex is net buyers or sellers over its current business cycle. Note, Pro Dex insiders must abide by specific rules, including filing SEC forms every time they buy or sell Pro Dex'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Pro Dex Management Efficiency

The company has return on total asset (ROA) of 0.0794 % which means that it generated a profit of $0.0794 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1068 %, meaning that it created $0.1068 on every $100 dollars invested by stockholders. Pro Dex's management efficiency ratios could be used to measure how well Pro Dex manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.13 in 2024. Return On Assets is likely to rise to 0.13 in 2024. At this time, Pro Dex's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 25.2 M in 2024, whereas Intangible Assets are likely to drop slightly above 88.5 K in 2024.
The company currently holds 14.79 M in liabilities with Debt to Equity (D/E) ratio of 0.67, which is about average as compared to similar companies. Pro-Dex has a current ratio of 2.69, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Pro Dex until it has trouble settling it off, either with new capital or with free cash flow. So, Pro Dex's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pro-Dex sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pro to invest in growth at high rates of return. When we think about Pro Dex's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

CHAIRMAN Age

David KingLaboratory
61
Adam SchechterLaboratory
59
Cesar AlvarezMednax Inc
71
Isaiah HarrisCigna Corp
68
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company was founded in 1978 and is headquartered in Irvine, California. Pro Dex operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 134 people. Pro Dex (PDEX) is traded on NASDAQ Exchange in USA. It is located in 2361 McGaw Avenue, Irvine, CA, United States, 92614 and employs 145 people. Pro Dex is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Pro-Dex Leadership Team

Elected by the shareholders, the Pro Dex's board of directors comprises two types of representatives: Pro Dex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pro. The board's role is to monitor Pro Dex's management team and ensure that shareholders' interests are well served. Pro Dex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pro Dex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nicholas Swenson, Independent Chairman of the Board
Richard Kirk, CEO and President COO, Director and Member of Investment Committee
William Farrell, Independent Director
Raymond Cabillot, Independent Director
Alisha Charlton, CFO Secretary
David Hovda, Independent Director

Pro Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pro Dex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pro Dex in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pro Dex's short interest history, or implied volatility extrapolated from Pro Dex options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pro-Dex using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Pro-Dex offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pro Dex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pro Dex Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pro Dex Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pro Dex. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For more information on how to buy Pro Stock please use our How to Invest in Pro Dex guide.
Note that the Pro-Dex information on this page should be used as a complementary analysis to other Pro Dex's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Pro Stock analysis

When running Pro Dex's price analysis, check to measure Pro Dex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Dex is operating at the current time. Most of Pro Dex's value examination focuses on studying past and present price action to predict the probability of Pro Dex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Dex's price. Additionally, you may evaluate how the addition of Pro Dex to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is Pro Dex's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pro Dex. If investors know Pro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pro Dex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.81)
Earnings Share
0.84
Revenue Per Share
13.601
Quarterly Revenue Growth
0.116
Return On Assets
0.0794
The market value of Pro-Dex is measured differently than its book value, which is the value of Pro that is recorded on the company's balance sheet. Investors also form their own opinion of Pro Dex's value that differs from its market value or its book value, called intrinsic value, which is Pro Dex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pro Dex's market value can be influenced by many factors that don't directly affect Pro Dex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pro Dex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pro Dex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pro Dex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.